FDA Inspection 1251708 — Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank

Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank — FEI 1077548

The FDA completed an inspection of Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank on September 6, 2024 in Keesler Afb, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 6, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Keesler Afb, MS (United States)